Moltech Innovations is a biotech company that specializes in use of generative AI to accelerate the discovery of small molecules designed to treat chronic diseases.

By using advanced AI, Moltech aims to address one of the biggest challenges in drug discovery: the time and cost associated with developing new treatments. Traditional drug development is very slow and expensive, often taking years to bring a molecule from the discovery phase to clinical trials. With AI, Moltech is able to reduce timelines, rapidly testing virtual models and predicting the efficacy of molecules. Moltech’s platform can continually improve molecules, fine-tuning their properties to enhance drug effectiveness, minimize side effects, and improve overall safety profiles. Moltech Innovations enables not only faster and cheaper but also more efficient design of small molecules for treatment of chronic diseases that affect millions of people worldwide.